Funding Tracker/Aevius

Launch funding · Clinical AI & Documentation · United States

Aevius raises $22M

Announced November 17, 2026

The round

Aevius announced a Launch funding round of $22M on November 17, 2026, led by Insight Partners.

The SignalAevius, a Mass General Brigham spinout, launched with $22 million in funding led by Insight Partners to support model and product development, team expansion and commercial deployment of its multimodal patient representation.

Aevius logo

What Aevius does

Mass General Brigham spinout building AI models that make medicine computable.

Aevius is a clinical intelligence company and Mass General Brigham spinout, founded to make medicine computable. It develops AI models that learn from structured, unstructured and specialty multimodal medical data, including medical records and imaging, to create a refreshable multimodal patient representation that can be updated as new information arrives. Organizations can use it to forecast outcomes, find clinically similar patients, identify and stratify populations and monitor change over time. Aevius is bringing the technology to health systems, payers and life sciences companies. On November 17, 2026, it launched with $22 million in funding led by Insight Partners.

Full Aevius profile
Company
Aevius
Amount
$22M
Stage
Launch funding
Announced
November 17, 2026
Vertical
Clinical AI & Documentation
Country
United States
Headquarters
Boston, MA, United States

More Clinical AI & Documentation rounds

Your daily HealthTech Signal

No hype. Just signal.

Get the latest HealthTech news, understand why it matters, and see where the industry is headed.

5-minute read Delivered daily Unsubscribe anytime

Read by teams at companies like:

Mayo Clinic logoMayo ClinicCleveland Clinic logoCleveland ClinicJohns Hopkins logoJohns HopkinsKaiser Permanente logoKaiser PermanenteEpic logoEpicPhilips logoPhilipsMedtronic logoMedtronicGE HealthCare logoGE HealthCare